Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsORALGeneric

MEPRON

ATOVAQUONE

Standard Dose
250MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Max Dose
Refer to approved labeling
Primary Use
Review priority: PRIORITY Marketing status: Discontinued
Summary

Approval overview MEPRON is listed in Drugs@FDA under application 020259 (NDA).

Review priority: PRIORITY Marketing status: Discontinued Active ingredient ATOVAQUONE Form and strength TABLET;ORAL - 250MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** Sponsor GLAXOSMITHKLINE LLC Submission history Latest submission status date: 1992-11-25 00:00:00.

Structured Monograph

Clinical summary

Approval overview MEPRON is listed in Drugs@FDA under application 020259 (NDA). Review priority: PRIORITY Marketing status: Discontinued Active ingredient ATOVAQUONE Form and strength TABLET;ORAL - 250MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** Sponsor GLAXOSMITHKLINE LLC Submission history Latest submission status date: 1992-11-25 00:00:00. Submission type: ORIG.

Monitoring

  • • Marketing status: Discontinued
  • • Review priority: PRIORITY

Interaction Notes

  • No interaction notes stored yet.